Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,614 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02064491 | Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC | completed | Phase 2 | 18 | Finnish Lung Cancer GroupOTHER | 1 | Jun 22, 2017 | clinicaltrials |
| NCT00280150 | Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 46 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 19, 2017 | clinicaltrials |
| NCT01685060 | LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib | completed | Phase 2 | 140 | Novartis PharmaceuticalsINDUSTRY | 12 | Jun 19, 2017 | clinicaltrials |
| NCT02040662 | Comparison of Efficacy of Paravertebral and Epidural Analgesia After Videothoracoscopic Lung Lobectomy | completed | Phase 2 | 120 | Pulmonary Hospital ZakopaneOTHER | 1 | Jun 12, 2017 | clinicaltrials |
| NCT00550537 | Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 116 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 8, 2017 | clinicaltrials |
| NCT01948141 | Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens | completed | Phase 2 | 6 | Roswell Park Cancer InstituteOTHER | 1 | Jun 8, 2017 | clinicaltrials |
| NCT00043862 | The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)((SCLC)) | completed | Phase 2 | 60 | GlaxoSmithKlineINDUSTRY | 1 | May 31, 2017 | clinicaltrials |
| NCT00376987 | Zinc Supplements in Lowering Cadmium Levels in Smokers | completed | Phase 2 | 61 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00534001 | Bupropion in Helping Adults Stop Smoking | completed | Phase 2 | 95 | Roswell Park Cancer InstituteOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00942825 | Triplet Combination First Line Treatment in Non Small Cell Lung Cancer (NSCLC)(CBP08-02) | completed | Phase 2 | 195 | CanBas Co. Ltd.INDUSTRY | 1 | May 24, 2017 | clinicaltrials |
| NCT01438307 | Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 28 | University of Alabama at BirminghamOTHER | 1 | May 24, 2017 | clinicaltrials |
| NCT01166191 | Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC) | completed | Phase 2 | 60 | Maastricht Radiation OncologyOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT01166204 | Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD) | completed | Phase 2 | 300 | Maastricht Radiation OncologyOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT00480831 | A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g) | completed | Phase 2 | 128 | Genentech, Inc.INDUSTRY | 0 | May 18, 2017 | clinicaltrials |
| NCT00691132 | Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers | completed | Phase 2 | 107 | University of MinnesotaOTHER | 1 | May 12, 2017 | clinicaltrials |
| NCT02483052 | RejuvenAir Lobectomy for Safety and Histology(LobectomyCAN) | completed | Phase 1 / Phase 2 | 6 | CSA Medical, Inc.INDUSTRY | 1 | May 11, 2017 | clinicaltrials |
| NCT00076856 | Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) | completed | Phase 2 | 95 | Merck Sharp & Dohme LLCINDUSTRY | 0 | May 9, 2017 | clinicaltrials |
| NCT00831545 | Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064) | completed | Phase 2 | 162 | Merck Sharp & Dohme LLCINDUSTRY | 0 | May 9, 2017 | clinicaltrials |
| NCT01023347 | A Trial of Paclitaxel (Genexol®) and Cisplatin Versus Paclitaxel Loaded Polymeric Micelle (Genexol-PM®) and Cisplatin in Advanced Non Small Cell Lung Cancer | completed | Phase 2 | 276 | Samyang Biopharmaceuticals CorporationINDUSTRY | 1 | May 9, 2017 | clinicaltrials |
| NCT00408499 | Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 64 | University of California, DavisOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT00188214 | CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy | completed | Phase 2 | 38 | University Health Network, TorontoOTHER | 1 | May 4, 2017 | clinicaltrials |
| NCT00372203 | Endobronchial Ultrasound vs Mediastinoscopy in NSCLC | completed | Phase 2 | 200 | University Health Network, TorontoOTHER | 1 | May 4, 2017 | clinicaltrials |
| NCT00408460 | Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 34 | University of WashingtonOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT01493843 | Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer | completed | Phase 2 | 501 | Genentech, Inc.INDUSTRY | 16 | Apr 25, 2017 | clinicaltrials |
| NCT00283244 | Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC | completed | Phase 2 | 147 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 24, 2017 | clinicaltrials |
| NCT01138163 | Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer | completed | Phase 2 | 121 | Peregrine PharmaceuticalsINDUSTRY | 5 | Apr 19, 2017 | clinicaltrials |
| NCT01160601 | Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer | completed | Phase 2 | 86 | Peregrine PharmaceuticalsINDUSTRY | 5 | Apr 19, 2017 | clinicaltrials |
| NCT00622193 | Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer | completed | Phase 2 | 228 | Helsinn Therapeutics (U.S.), IncINDUSTRY | 2 | Apr 14, 2017 | clinicaltrials |
| NCT01153984 | A Study to Assess Biomarkers Impact on Participants Response to Erlotinib Treatment for First-line Non-Small Cell Lung Cancer With Endothelial Growth Factor Receptor (EGFR) Activating Mutations(BIOTEC) | completed | Phase 2 | 23 | Hoffmann-La RocheINDUSTRY | 1 | Apr 13, 2017 | clinicaltrials |
| NCT01951690 | Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer | completed | Phase 2 | 55 | Verastem, Inc.INDUSTRY | 1 | Apr 13, 2017 | clinicaltrials |
| NCT00642759 | Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 36 | Massachusetts General HospitalOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT00103116 | Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer | completed | Phase 2 | 32 | Edward HirschowitzOTHER | 1 | Apr 4, 2017 | clinicaltrials |
| NCT00453362 | A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib | completed | Phase 1 / Phase 2 | 88 | Genentech, Inc.INDUSTRY | 0 | Mar 31, 2017 | clinicaltrials |
| NCT00854308 | A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib) | completed | Phase 2 | 137 | Genentech, Inc.INDUSTRY | 0 | Mar 31, 2017 | clinicaltrials |
| NCT00499655 | Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer | completed | Phase 2 | 107 | City of Hope Medical CenterOTHER | 1 | Mar 29, 2017 | clinicaltrials |
| NCT00215930 | The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 53 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00226577 | Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer. | completed | Phase 2 | 52 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00226590 | Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC | completed | Phase 2 | 39 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT00326599 | Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 101 | Alliance for Clinical Trials in OncologyOTHER | 1 | Mar 21, 2017 | clinicaltrials |
| NCT00454194 | Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 110 | Alliance for Clinical Trials in OncologyOTHER | 1 | Mar 21, 2017 | clinicaltrials |
| NCT00963807 | A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC | completed | Phase 2 | 26 | National Cancer Institute (NCI)NIH | 1 | Mar 17, 2017 | clinicaltrials |
| NCT00094861 | Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 100 | Swedish Orphan BiovitrumINDUSTRY | 0 | Mar 14, 2017 | clinicaltrials |
| NCT00188617 | Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC | completed | Phase 2 | 35 | University Health Network, TorontoOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT01262820 | Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab(LCCC0921) | completed | Phase 2 | 15 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT00227019 | Phase 2 Trial of Bevacizumab in Combination With Pemetrexed | completed | Phase 2 | 16 | Heather WakeleeOTHER | 1 | Mar 6, 2017 | clinicaltrials |
| NCT00231465 | Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT00775385 | TAilored Post-Surgical Therapy in Early Stage NSCLC(TASTE) | completed | Phase 2 / Phase 3 | 152 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT00874107 | Efficacy/Safety of Imprime PGG® Injection With Bevacizumab and Paclitaxel/Carboplatin in Patients With Untreated Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 90 | HiberCell, Inc.INDUSTRY | 2 | Mar 3, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Jun 22, 2017source: clinicaltrials